1. Schipper H, Levitt M. Measuring quality of life: risks and benefits. Cancer Treat Rep 1985; 69: 1115?1123.
2. Barofsky I, Sugarbaker PH. Cancer. In: Spilker B, ed. Quality of Life Assessments in Clinical Trials. New York: Raven Press, 1990.
3. Moinpoir CA, Feigl P, Metch B. Quality of life ends points in cancer clinical trials. J Natl Cancer Inst 1989; 81: 485?495.
4. Moinpour CM, Hayden KA, Thompson IM, et al. Quality of life assessment in southwest oncology group trials. Oncology 1990; 4: 79?89.
5. Johnson JR, Temple R. Food and Drug Administration requirements for approval of new anticancer drugs. Cancer Treat Rep 1985; 69: 1155?1157.